Stanford-StartX Fund-backed microbial diagnostics and wellness product developer UBiome has raised $83m in series C funding.

UBiome, a US-based microbial genomics technology developer backed by the Stanford-StartX Fund, has raised $83m in series C funding from investors including Dentsu Ventures, the corporate venturing vehicle formed by marketing firm Dentsu.
The round was led by venture capital fund OS Fund and included 8VC, Y Combinator and undisclosed new and existing investors. It increased the company’s funding to $105m altogether.
Founded in 2012, UBiome is developing wellness products and diagnostics tests focusing on diseases such as…